Publications
View AllLecanemab appropriate use recommendations for clinical practice in the UK
Lecanemab is an anti-amyloid monoclonal antibody, recently approved in the UK as a treatment for mild cognitive impairment (MCI) and mild dementia due to Alzheimer’s disease (AD...
Affiliated Researchers
Institution Info
- Type
- healthcare
- Country
- GB
- Publications
- 3
- Citations
- 1,181
External Links
Identifiers
- ROR
- https://ror.org/05x3jck08